← Back to Search

Training Early Social Language in Autism (TESLA Trial)

N/A
Waitlist Available
Led By Helen Tager-Flusberg, PhD
Research Sponsored by Boston University Charles River Campus
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessment occurs at week 1, week 6, and week 12, with an intervention in weeks 2-11
Awards & highlights
No Placebo-Only Group

Summary

The aim of the study is to determine whether a targeted behavioral intervention can lead to both changes in early communication skills and in neural responses in toddlers and preschoolers with autism.

Eligible Conditions
  • Autism Spectrum Disorder
  • Autism

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessment occurs at week 1, week 6, and week 12, with an intervention in weeks 2-11
This trial's timeline: 3 weeks for screening, Varies for treatment, and assessment occurs at week 1, week 6, and week 12, with an intervention in weeks 2-11 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in EEG Frequency Data- Grasping Objects
Change in EEG Frequency Data- Observing actions
Change in EEG Frequency Data- Resting State
+6 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Parent EducationExperimental Treatment1 Intervention
Parent education intervention focusses on parenting a child with autism.
Group II: JasperExperimental Treatment1 Intervention
JASPER (Joint Attention Symbolic Play Engagement Regulation) is a targeted intervention that focusses on early communication skills.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Parent Education
2016
N/A
~620

Find a Location

Who is running the clinical trial?

Boston Medical CenterOTHER
404 Previous Clinical Trials
884,805 Total Patients Enrolled
5 Trials studying Autism Spectrum Disorder
431 Patients Enrolled for Autism Spectrum Disorder
University of Maryland, College ParkOTHER
159 Previous Clinical Trials
46,363 Total Patients Enrolled
Boston University Charles River CampusLead Sponsor
121 Previous Clinical Trials
13,350 Total Patients Enrolled
5 Trials studying Autism Spectrum Disorder
271 Patients Enrolled for Autism Spectrum Disorder
University of ChicagoOTHER
1,059 Previous Clinical Trials
765,446 Total Patients Enrolled
5 Trials studying Autism Spectrum Disorder
150 Patients Enrolled for Autism Spectrum Disorder
Centre National de la Recherche Scientifique, FranceOTHER
86 Previous Clinical Trials
32,239 Total Patients Enrolled
1 Trials studying Autism Spectrum Disorder
8 Patients Enrolled for Autism Spectrum Disorder
University of California, Los AngelesOTHER
1,567 Previous Clinical Trials
10,312,088 Total Patients Enrolled
25 Trials studying Autism Spectrum Disorder
4,299 Patients Enrolled for Autism Spectrum Disorder
Helen Tager-Flusberg, PhDPrincipal InvestigatorBoston University Charles River Campus
3 Previous Clinical Trials
160 Total Patients Enrolled
3 Trials studying Autism Spectrum Disorder
160 Patients Enrolled for Autism Spectrum Disorder
~11 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top